Results 131 to 140 of about 11,492 (193)

Retrospective analysis of platelet to high-density lipoprotein cholesterol ratio in obese children with metabolic dysfunction-associated fatty liver disease. [PDF]

Transl Pediatr
Li G, Wang C, Yang W.
europepmc   +1 more source

Demystifying MAFLD: Fatty Liver Disease Mgmt in Primary Care

Objectives Understand the history & evolution of nomenclature of fatty liver disease Review guidance on MAFLD/MASH management Discuss updates to medical management of MAFLD/MASH Apply knowledge to clinical cases Highlight clinical ...
Santos, MD, Jasmine M.
core   +1 more source

Mediation of the association between physical activity and metabolic dysfunction-associated fatty liver disease in children and adolescents by inflammatory markers: an analysis of 2017‒2020 NHANES data. [PDF]

Clinics (Sao Paulo)
Zhang C, Li X.
europepmc   +1 more source

Survival after curative hepatectomy for hepatocellular carcinoma in patients with and without MAFLD: a western cohort study. [PDF]

Front Oncol
Molinari M, Sethi V, Kaltenmeier C, Abdullah A, Demirors B, Yu-Sheng Lin M, Mial-Anthony J, Arefan D, Wu S, Buros C, Liu H, Elias C, Minervini M, Tohme S, Zhang X, Geller D, Furlan A.   +16 more
europepmc   +1 more source

Predictive Value of the Triglyceride-Glucose Index for Metabolic-Associated Fatty Liver Disease in Individuals with Different Metabolic Obese Phenotypes

Diabetes, Metabolic Syndrome and Obesity
Dan Lv,1 Zepu Wang,2 Huanxin Liu,1 Cuiqiao Meng1 1Physical Examination Center, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China; 2Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic ...
Lv D, Wang Z, Liu H, Meng C
doaj  

Plant metabolites targeting the AMPK pathway: advances in the mechanisms of action in the context of MAFLD. [PDF]

Front Pharmacol
Li M, Wang H, Cui D, Li M, Niu Y, Yu J, Dang X, Wang J.   +7 more
europepmc   +1 more source

Integrated Plasma and Tissue Lipid Profiling Demonstrates a Distinctive Metabolic Profile in MAFLD-Associated Non-Cirrhotic Hepatocellular Carcinoma. [PDF]

Int J Mol Sci
Safri F, Pickford R, Xu Y, Yang W, Nguyen R, Yuen L, Lam V, Nahm C, Pang T, George J, Qiao L.   +10 more
europepmc   +1 more source

AI-assisted segmentation-based fusion model integrating deep learning, radiomics, and clinical parameters for identifying coronary heart disease risk in patients with MAFLD. [PDF]

Front Endocrinol (Lausanne)
Qi L, Zhang S, Wang B, Yang M, Li Y, Li B, Xue J, Li X.   +7 more
europepmc   +1 more source

Multi-Target Anti-Steatotic Effects of Andrographolide in MAFLD: Insights from Network Pharmacology and in vitro Study. [PDF]

J Exp Pharmacol
Abu Omaima HAA, Burhan AH, Aboomaima WAA, Mahmoudi A.   +3 more
europepmc   +1 more source

Potential mechanisms by which microbiota-accessible carbohydrates regulate hepatic lipid metabolism in MAFLD via the gut-liver axis. [PDF]

Front Microbiol
Peng J, Gao X, Chen G, Yan A, Yu Q, Tian W, Cai K.   +6 more
europepmc   +1 more source